Genome Bio-Tech Ltd - Company Profile

It is a chemicals public limited company based in New Delhi, Delhi, India, established in 2001.
2001 New Delhi, Delhi, India Struck Off
Last Updated:
About Genome Bio-Tech Ltd

Genome Bio-Tech Ltd, a struck off public limited company, was established on 09 July 2001 in New Delhi, Delhi, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239DL2001PLC111601. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Vinod Kumar (Director), Krushna Chandra Hota (Director), Parveen Monga (Director). Past directors included Shikhar Chand Sethia, Lalit Ramesh Joshi, Upendra Pandey. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at S-453, Basement, Greater Kailash-Ii, New Delhi, Delhi, 110048.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL2001PLC111601

  • Registration Number

    111601

  • Incorporation Date

    09 July 2001

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 24 Year, 7 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Genome Bio-Tech Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Genome Bio-Tech Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Genome Bio-Tech Ltd?
Current Directors
Name Designation Appointment Date Status
Vinod Kumar Director 26 Oct 2011 Current
Krushna Chandra Hota Director 10 May 2013 Current
Parveen Monga Director 26 Oct 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Jan 2009 Past
Pramod Abcsdd Director 15 May 2013 Past
Pramod Abcsdd Additional Director 28 Oct 2011 Past
Pramod Abcsdd Director 28 Oct 2011 Past
Pramod Abcsdd Director 28 Oct 2011 Past
Pramod Abcsdd Director 28 Oct 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genome Bio-Tech.

Enhance accessibility to Genome Bio-Tech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Genome Bio-Tech revenue growth over time
Genome Bio-Tech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genome Bio-Tech?

Unlock access to Genome Bio-Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Genome Bio-Tech?

Unlock and access historical data on people associated with Genome Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genome Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genome Bio-Tech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genome Bio-Tech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Genome Bio-Tech Ltd last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Krushna Chandra Hota was appointed as a Director was appointed as a Director on 10 May 2013 & has been associated with this company since 12 years 9 months . was documented.

  • Balance Sheet

    The activity Genome Bio-Tech Ltd has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Delhi. was completed.

  • Director Appointment

    Vinod Kumar was appointed as a Director was appointed as a Director on 26 Oct 2011 & has been associated with this company since 14 years 3 months . was recorded as a recent event.

  • Director Appointment

    Parveen Monga was appointed as a Director was appointed as a Director on 26 Oct 2011 & has been associated with this company since 14 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Genome Bio-Tech Ltd was registered on 09 Jul 2001 with Roc Delhi & aged 24 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genome Bio-Tech Ltd?

The CIN of Genome Bio-Tech Ltd is U24239DL2001PLC111601.

Where is Genome Bio-Tech Ltd headquartered?

Genome Bio-Tech Ltd is headquartered at S-453, Basement, Greater Kailash-Ii, New Delhi, Delhi, 110048.

When was Genome Bio-Tech Ltd incorporated?

Genome Bio-Tech Ltd was incorporated on 09 July 2001.

Who are the current directors of Genome Bio-Tech Ltd?

The current directors of Genome Bio-Tech Ltd are

What is the primary industry of Genome Bio-Tech Ltd?

The primary industry of Genome Bio-Tech Ltd is Chemicals.

Is Genome Bio-Tech Ltd a listed company?

Genome Bio-Tech Ltd is unlisted.

What is the capital structure of Genome Bio-Tech Ltd?

The authorized capital of Genome Bio-Tech Ltd is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available